Portland School District Sues E-Cigarette Company Juul Labs

Oct.05.2022
Portland School District Sues E-Cigarette Company Juul Labs
Portland Public Schools sues Juul Labs for promoting e-cigarettes to teens, leading to illegal drug abuse.

The Portland Public Schools district has become the latest district to sue e-cigarette company Juul Labs, accusing the company of marketing its products to teenagers and contributing to the illegal drug use in the city's schools.


According to a lawsuit filed in the US District Court in Portland, approximately half of the disciplinary actions related to drug abuse in the 2021-22 school year were due to vaping and e-cigarette use.


As a result, the school district has added information on electronic cigarettes and nicotine addiction to its "Insight" curriculum, which is a 14-week student and parent education program aimed at students who violate the district's drug and tobacco policies.


A lawsuit alleges that, similar to the nationwide rise in electronic cigarette usage, there is a high rate of teenagers in Portland public schools using e-cigarettes. The lawsuit states that from 2017 to 2019, the usage of e-cigarettes among 11th-grade students in Multnomah County rose from approximately 10% to 21%. Juul's founders, Adam Bowen and James Monsees, are accused of developing a highly addictive product to expand their loyal user base and using tactics similar to the tobacco industry to market it to young people.


It accuses the company of using child-friendly flavors to appeal to young people without ensuring that the flavorings can be safely inhaled.


A recently filed lawsuit alleges that an electronic cigarette manufacturer has been engaging in both environmental pollution and extortion. The school district is requesting that a judge order the company to cease enabling teenage addiction and award damages to help cover costs for prevention education, addiction treatment, and on-campus monitoring. They are also seeking punitive damages.


Statement:


This article is compiled from third-party information and is solely for the purpose of industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's contents. The compilation of this article is only for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS is entirely aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international views and positions.


The copyright of the compiled information belongs to the original media outlet and author. If there is any copyright infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
The UK Vaping Industry Association said it will launch the ninth annual VApril campaign next month. The association described VApril as the world’s largest vape awareness initiative and said it has for almost a decade supported adult smokers looking to quit through vaping by providing evidence-based information, expert insights and practical guidance
Mar.24 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai